Zhongchao (NASDAQ:ZCMD) Stock Rating Lowered by Wall Street Zen

Zhongchao (NASDAQ:ZCMD) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings upgraded shares of Zhongchao from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 24th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Zhongchao Trading Down 0.4%

NASDAQ ZCMD opened at $0.76 on Friday. Zhongchao has a 12 month low of $0.71 and a 12 month high of $967.20. The company’s fifty day moving average price is $1.14 and its two-hundred day moving average price is $72.26.

Zhongchao Company Profile

Zhongchao Inc is a China-based healthcare services company that provides medical education and patient-management services. The company focuses on supporting healthcare professionals and patients through digital platforms, educational programs and related healthcare resources.

Its business activities have included continuing medical education for physicians and other medical professionals, as well as disease-management and patient-support services. Zhongchao has particularly emphasized oncology-related healthcare education and management, helping connect medical information, professional training and patient services.

The company primarily serves the healthcare market in China through online and offline offerings.